SEARCH

SEARCH BY CITATION

Figure S1. Induction of DNA adducts and 8-hydroxy-deoxyguanosine lesions following AFB1 exposure in HepG2.

Figure S2. Induction of senescence arrest and apoptosis in HepG2 cells by Adriamycin, but not AFB1 in HepG2.

Figure S3. Time-dependent increase in 53BP1 foci-positive HepG2 cells under AFB1 exposure.

Figure S4. The duration of 53BP1 foci after 24 h of exposure to AFB1 in HepG2.

Figure S5. Incomplete DNA damage checkpoint response of Huh7 hepatoma cells to AFB1.

Figure S6. Induction of 8-hydroxy-deoxyguanosine lesions and double-strand breaks in HCT116 isogenic clones following AFB1 exposure.

Figure S7. Increased DNA damage-induced foci detection after exposure of HCT116 isogenic clones to AFB1.

Figure S8. Incomplete DNA damage checkpoint response of wild-type p53 HCT116 cells to AFB1.

Figure S9. p53-dependent and p53-independent cell cycle arrest in HCT116 isogenic clones after Adriamycin treatment.

Figure S10. Lack of cell cycle arrest of HCT116 isogenic clones in response to AFB1-induced DNA damage.

Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.

FilenameFormatSizeDescription
LIV_2474_sm_supplfig.pdf1496KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.